GG

Gopal Girdharlal Vaghasia

Active Director Director DIN 03591113
DIN 03591113 First appointment Dec 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Dec 2011
Shareholding value •••• Premium profile

About Gopal Girdharlal Vaghasia

Data last updated:

Gopal Girdharlal Vaghasia is a Director at Adnova Healthcare Private Limited (since 2015), Director at Android Bioscience Private Limited (since 2016) and Director at Revo Medicare Private Limited (since 2018). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹9.45 Cr; the largest is Adnova Healthcare Private Limited at ₹9.45 Cr (FY 2025). Earlier, Gopal Girdharlal Vaghasia was a Whole-Time Director at Sunvij Drugs Private Limited (2011–2016) and Director at 4Care Lifescience Private Limited (2012–2013).

DIN 03591113
Primary Designation Director
Industry Pharma
First Appointment 24 Dec 2011
Oldest Company Age 14 yrs
Largest company Adnova Healthcare Private Limited · ₹9.45 Cr (FY 2025)
Combined revenue ₹9.45 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Adnova Healthcare Private Limited U24233GJ2015PTC084018
Director03 Aug 20152015₹9.45 Cr (FY 2025)Active
Android Bioscience Private Limited U24230GJ2012PTC070654
Director21 Nov 20162012₹1,024 (FY 2025)Active
Revo Medicare Private Limited U24297GJ2012PTC071116
Director17 Sep 20182012Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sunvij Drugs Private Limited U24232GJ1995PTC077943
Whole-Time Director24 Dec 20111995₹24.23 Cr (FY 2024)Active
4Care Lifescience Private Limited U24239GJ2012PTC068900
Director06 Feb 20122012₹32.70 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Android Bioscience Private Limited
Adnova Healthcare Private Limited
Revo Medicare Private Limited
Sunvij Drugs Private Limited
Premium access

Shareholding and investment profile for Gopal Girdharlal Vaghasia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gopal Girdharlal Vaghasia

Gopal Girdharlal Vaghasia currently holds 3 directorships: Adnova Healthcare Private Limited (Director, since 03 Aug 2015, revenue ₹9.45 Cr (FY 2025)); Android Bioscience Private Limited (Director, since 21 Nov 2016, revenue ₹1,024 (FY 2025)); Revo Medicare Private Limited (Director, since 17 Sep 2018).

Gopal Girdharlal Vaghasia was first appointed on 24 Dec 2011 as Whole-Time Director at Sunvij Drugs Private Limited. The most recent appointment on record is 17 Sep 2018 at Revo Medicare Private Limited.

The 2 current companies of Gopal Girdharlal Vaghasia that report revenue have a combined latest revenue of ₹9.45 Cr: Adnova Healthcare Private Limited ₹9.45 Cr (FY 2025); Android Bioscience Private Limited ₹1,024 (FY 2025).

Gopal Girdharlal Vaghasia held 2 earlier board appointments: Sunvij Drugs Private Limited (Whole-Time Director, 24 Dec 2011 to 05 Aug 2016); 4Care Lifescience Private Limited (Director, 06 Feb 2012 to 24 May 2013).

The current boards of Gopal Girdharlal Vaghasia's companies include Biraj Shailesh Thakkar (Adnova Healthcare Private Limited), Divyesh Vinodkumar Sakariya (Adnova Healthcare Private Limited), Krishna Gopal Vaghasia (Adnova Healthcare Private Limited), Ramesh Veljibhai Pansuria (Adnova Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available